Derm-Biome Pharmaceuticals is Biotechnology in Canada that focus on bacterial infections business. Founded in 2018. They cover business area such as Provider, healthcare product, skin disease, natural compound derivative, atopic dermatitis, acne, psoriasis, rosacea, minor skin bacterial infection, patient, skin cancer, surround skin.
2018
( 6 years old in 2024 )
Bacterial Infections
-
1310 Richards Street
2704
Vancouver, British Columbia V6B 3G6
Canada
Private
Providerhealthcare productskin diseasenatural compound derivativeatopic dermatitisacnepsoriasisrosaceaminor skin bacterial infectionpatientskin cancersurround skin
* We use standard office opening hours in near Derm-Biome Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Derm-Biome Pharmaceuticals is Biotechnology business from Canada that founded in 2018 (6 years old in 2024), Derm-Biome Pharmaceuticals business is focusing on Bacterial Infections.
Derm-Biome Pharmaceuticals headquarter office and corporate office address is located in 1310 Richards Street 2704 Vancouver, British Columbia V6B 3G6 Canada.
Derm-Biome Pharmaceuticals was founded in Canada.
In 2024, Derm-Biome Pharmaceuticals is currently focus on bacterial infections sector.
Above is snippet of Google Trends for "bacterial infections" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Derm-Biome Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.